BioCentury | Jun 17, 2019
Company News

Array takeout buoys biotechs, strengthens Pfizer in targeted oncology

...were its purchase of Medivation Inc. for $13.6 billion in 2016, and its acquisition of Hospira Inc....
BioCentury | May 15, 2019
Politics & Policy

DOJ death penalty opinion could hobble FDA oversight of countermeasures, street drugs

...thiopental, an anesthetic that is no longer manufactured or marketed in the U.S. In 2011, Hospira Inc....
BioCentury | Nov 16, 2018
Clinical News

Pfizer launches U.S.’s first biosimilar epoetin

...First Epoetin Alfa Biosimilar in U.S." ). Pfizer gained Retacrit through its 2015 acquisition of Hospira Inc....
BioCentury | Oct 1, 2018
Company News

Pfizer COO Bourla to succeed Read as CEO

...unit. He oversaw the growth of the pharma's injectables business with the successful acquisition of Hospira Inc....
BioCentury | Aug 3, 2018
Company News

Celltrion wins another biosimilar infliximab lawsuit

...to be invalid in a separate patent infringement case filed in 2015 against Celltrion and Hospira Inc....
BioCentury | Aug 1, 2018
Company News

Celltrion wins another biosimilar infliximab lawsuit

...to be invalid in a separate patent infringement case filed in 2015 against Celltrion and Hospira Inc....
BioCentury | Jul 13, 2018
Company News

Novartis to spin out Alcon unit

...and will step down from Novartis' executive committee, effective July 1. Ball was CEO of Hospira Inc....
BioCentury | Jun 29, 2018
Company News

Novartis to spin out Alcon unit

...and will step down from Novartis' executive committee, effective July 1. Ball was CEO of Hospira Inc....
...March (see "GSK Buying Out Novartis' Stake in Consumer Health JV" ). Jennie Walters brolucizumab (RTH258, esba1008) Alcon Inc. Hospira Inc. Novartis...
BioCentury | May 18, 2018
Clinical News

FDA approves Pfizer's Retacrit, first epoetin alfa biosimilar in U.S.

...U.S. and worldwide sales of $297 million. Pfizer gained Retacrit through its 2015 acquisition of Hospira Inc....
BioCentury | May 15, 2018
Company News

FDA approves Pfizer's Retacrit, first epoetin alfa biosimilar in U.S.

...U.S. and worldwide sales of $297 million. Pfizer gained Retacrit through its 2015 acquisition of Hospira Inc....
Items per page:
1 - 10 of 337
BioCentury | Jun 17, 2019
Company News

Array takeout buoys biotechs, strengthens Pfizer in targeted oncology

...were its purchase of Medivation Inc. for $13.6 billion in 2016, and its acquisition of Hospira Inc....
BioCentury | May 15, 2019
Politics & Policy

DOJ death penalty opinion could hobble FDA oversight of countermeasures, street drugs

...thiopental, an anesthetic that is no longer manufactured or marketed in the U.S. In 2011, Hospira Inc....
BioCentury | Nov 16, 2018
Clinical News

Pfizer launches U.S.’s first biosimilar epoetin

...First Epoetin Alfa Biosimilar in U.S." ). Pfizer gained Retacrit through its 2015 acquisition of Hospira Inc....
BioCentury | Oct 1, 2018
Company News

Pfizer COO Bourla to succeed Read as CEO

...unit. He oversaw the growth of the pharma's injectables business with the successful acquisition of Hospira Inc....
BioCentury | Aug 3, 2018
Company News

Celltrion wins another biosimilar infliximab lawsuit

...to be invalid in a separate patent infringement case filed in 2015 against Celltrion and Hospira Inc....
BioCentury | Aug 1, 2018
Company News

Celltrion wins another biosimilar infliximab lawsuit

...to be invalid in a separate patent infringement case filed in 2015 against Celltrion and Hospira Inc....
BioCentury | Jul 13, 2018
Company News

Novartis to spin out Alcon unit

...and will step down from Novartis' executive committee, effective July 1. Ball was CEO of Hospira Inc....
BioCentury | Jun 29, 2018
Company News

Novartis to spin out Alcon unit

...and will step down from Novartis' executive committee, effective July 1. Ball was CEO of Hospira Inc....
...March (see "GSK Buying Out Novartis' Stake in Consumer Health JV" ). Jennie Walters brolucizumab (RTH258, esba1008) Alcon Inc. Hospira Inc. Novartis...
BioCentury | May 18, 2018
Clinical News

FDA approves Pfizer's Retacrit, first epoetin alfa biosimilar in U.S.

...U.S. and worldwide sales of $297 million. Pfizer gained Retacrit through its 2015 acquisition of Hospira Inc....
BioCentury | May 15, 2018
Company News

FDA approves Pfizer's Retacrit, first epoetin alfa biosimilar in U.S.

...U.S. and worldwide sales of $297 million. Pfizer gained Retacrit through its 2015 acquisition of Hospira Inc....
Items per page:
1 - 10 of 337